BR112021024147A2 - Métodos para limpar um material de cromatografia de troca iônica para reutilização e para purificar um polipeptídeo - Google Patents

Métodos para limpar um material de cromatografia de troca iônica para reutilização e para purificar um polipeptídeo

Info

Publication number
BR112021024147A2
BR112021024147A2 BR112021024147A BR112021024147A BR112021024147A2 BR 112021024147 A2 BR112021024147 A2 BR 112021024147A2 BR 112021024147 A BR112021024147 A BR 112021024147A BR 112021024147 A BR112021024147 A BR 112021024147A BR 112021024147 A2 BR112021024147 A2 BR 112021024147A2
Authority
BR
Brazil
Prior art keywords
reuse
ion exchange
methods
exchange chromatography
cleaning
Prior art date
Application number
BR112021024147A
Other languages
English (en)
Inventor
Amy Lim
F Quicho Donna
A Brown Jason
K Persson Josefine
L Wong Marc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BR112021024147A2 publication Critical patent/BR112021024147A2/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/50—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents
    • B01J49/53—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents for cationic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/203—Equilibration or regeneration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26—Cation exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/05—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds
    • B01J49/06—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds containing cationic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/05—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds
    • B01J49/07—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds containing anionic exchangers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/50—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents
    • B01J49/57—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents for anionic exchangers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography

Abstract

métodos para limpar um material de cromatografia de troca iônica para reutilização e para purificar um polipeptídeo. a presente invenção fornece métodos para limpar ou regenerar um material de cromatografia para reutilização. os métodos da invenção podem ser usados para limpar ou regenerar colunas de cromatografia de troca iônica para reutilização na fabricação em grande escala de produtos polipeptídicos múltiplos, em que a coluna de cromatografia de troca iônica é usada em modo de sobrecarga.
BR112021024147A 2019-06-05 2020-06-04 Métodos para limpar um material de cromatografia de troca iônica para reutilização e para purificar um polipeptídeo BR112021024147A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962857734P 2019-06-05 2019-06-05
PCT/US2020/036126 WO2020247634A1 (en) 2019-06-05 2020-06-04 A method for regeneration of an overload chromatography column

Publications (1)

Publication Number Publication Date
BR112021024147A2 true BR112021024147A2 (pt) 2022-01-11

Family

ID=71608042

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024147A BR112021024147A2 (pt) 2019-06-05 2020-06-04 Métodos para limpar um material de cromatografia de troca iônica para reutilização e para purificar um polipeptídeo

Country Status (14)

Country Link
US (1) US20220203347A1 (pt)
EP (1) EP3980153A1 (pt)
JP (1) JP2022535526A (pt)
KR (1) KR20220017436A (pt)
CN (1) CN114096553A (pt)
AR (1) AR119264A1 (pt)
AU (1) AU2020286442A1 (pt)
BR (1) BR112021024147A2 (pt)
CA (1) CA3140903A1 (pt)
IL (1) IL288518A (pt)
MX (1) MX2021014920A (pt)
SG (1) SG11202112816WA (pt)
TW (1) TW202112799A (pt)
WO (1) WO2020247634A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113842673B (zh) * 2021-09-07 2023-01-06 济宁海关综合技术服务中心 液相色谱柱再生方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
WO1991000360A1 (en) 1989-06-29 1991-01-10 Medarex, Inc. Bispecific reagents for aids therapy
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
AU8295491A (en) 1990-06-29 1992-01-23 Biosource Technologies Incorporated Melanin production by transformed microorganisms
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
JP4124480B2 (ja) 1991-06-14 2008-07-23 ジェネンテック・インコーポレーテッド 免疫グロブリン変異体
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
ATE297465T1 (de) 1991-11-25 2005-06-15 Enzon Inc Verfahren zur herstellung von multivalenten antigenbindenden proteinen
DE69334255D1 (de) 1992-02-06 2009-02-12 Novartis Vaccines & Diagnostic Marker für Krebs und biosynthetisches Bindeprotein dafür
WO1993016177A1 (en) 1992-02-11 1993-08-19 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
EP0656064B1 (en) 1992-08-17 1997-03-05 Genentech, Inc. Bispecific immunoadhesins
EP0752248B1 (en) 1992-11-13 2000-09-27 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
US6866844B2 (en) * 2002-11-07 2005-03-15 Biomarin Pharmaceutical Inc. Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
CA2447832C (en) 2000-12-22 2012-09-25 Jamshid Tanha Phage display libraries of human vh fragments
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
PL1639011T3 (pl) 2003-06-30 2009-05-29 Domantis Ltd Pegilowane przeciwciała jednodomenowe (dAb)
KR20070057839A (ko) 2004-08-19 2007-06-07 제넨테크, 인크. 변경된 이펙터 기능을 갖는 폴리펩티드 변이체
NZ580115A (en) 2004-09-23 2010-10-29 Genentech Inc Cysteine engineered antibody light chains and conjugates
CA2673851C (en) * 2007-01-22 2016-05-03 Genentech, Inc. Polyelectrolyte precipitation and purification of proteins
CA2799915C (en) * 2010-05-25 2023-09-26 Genentech, Inc. Methods of purifying polypeptides
US20140301977A1 (en) 2011-11-02 2014-10-09 Genentech, Inc. Overload and elute chromatography
KR20210025692A (ko) * 2011-12-22 2021-03-09 제넨테크, 인크. 이온 교환 막 크로마토그래피
SI3265557T1 (sl) * 2015-03-06 2020-02-28 F. Hoffmann-La Roche Ag Ultraprečiščena DsbA in DsbC ter postopki njune izdelave in uporabe
BE1025090B1 (fr) * 2017-03-30 2018-10-29 Univercells Sa Procede et kit de purification de proteines

Also Published As

Publication number Publication date
US20220203347A1 (en) 2022-06-30
AU2020286442A1 (en) 2021-12-16
SG11202112816WA (en) 2021-12-30
WO2020247634A1 (en) 2020-12-10
MX2021014920A (es) 2022-01-24
JP2022535526A (ja) 2022-08-09
IL288518A (en) 2022-01-01
CN114096553A (zh) 2022-02-25
AR119264A1 (es) 2021-12-09
KR20220017436A (ko) 2022-02-11
TW202112799A (zh) 2021-04-01
EP3980153A1 (en) 2022-04-13
CA3140903A1 (en) 2020-12-10

Similar Documents

Publication Publication Date Title
BR112015024414A2 (pt) derivados de oxopiridina substituída e uso desses no tratamento de distúrbios cardiovasculares
BR112017007777A2 (pt) canabidiol para uso, método para tratar convulsões atônicas, e, composição.
CL2022000036A1 (es) Polipéptidos modificados y usos de los mismos (divisional de solicitud no. 201900261)
BR112018010673A8 (pt) moléculas de anticorpo para april e seus usos
BR112016029157A8 (pt) processo para purificar a proteína de fusão tnfr:fc
BR112018011474A2 (pt) composição, e, método para tratar um sujeito que sofre de uma doença de armazenamento lisossômico.
BR112018016742A2 (pt) purificação de proteína
NI202000083A (es) Derivados sustituidos de la carboxamida dihidropirazolo pirazina
BR112014013957A8 (pt) regeneração ácida de resinas de troca ionica para aplicações industriais
BR112018007878A2 (pt) produtos de diatomita
BRPI0817262A2 (pt) Compostos derivados de biaril sulfonamida, composições farmacêuticas que os contêm, processo para sua fabricação, método e usos para o tratamento terapêutico e/ou profilático de doenças e usos na preparação de medicamentos
BRPI0620230B8 (pt) processo para a regeneração de catalisador ácido usado por alquilação
BR112018001278A2 (pt) ?produto de madeira fabricado e processo de produzir um produto de madeira fabricado?
BR112016026512A2 (pt) Processo para a produção de alquenóis e uso dos mesmos para a produção de 1,3-butadieno
BR112016014756A8 (pt) formulação de selante compreendendo fibrinogênio e zimogênios, seu método de fabricação, recipiente e uso
BR112018009312A2 (pt) método para promover eficiência de purificação de polipeptídeo contendo região de fc
WO2016077171A3 (en) Laser processing of transparent article using multiple foci
BRPI0510143A (pt) processo para a preparação de produtos quìmicos e farmacêuticos com cromatografia integrada de colunas múltiplas
BR112014003963A2 (pt) compostos e composições como inibidores de quinase c-kit
BR112015029538A2 (pt) adsorvente de aldeído, processo para a remoção de aldeído, processo para a produção de ácido acético e processo para a regeneração de adsorvente de aldeído
BRPI0809680A2 (pt) Compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por agonistas de lxr alfa e/ou lxr beta e uso dos compostos.
BR112021024147A2 (pt) Métodos para limpar um material de cromatografia de troca iônica para reutilização e para purificar um polipeptídeo
BR112019010622A2 (pt) composição, métodos para preparação da composição, para remover manchas e para limpeza, microcápsula, e, uso de pentano-1,2-diol.
AR104358A1 (es) Método para la purificación de proteínas
BRPI0915862A2 (pt) compostos derivados de tetraidrocinolina, processo para sua fabricação, composição farmacêutica que os compreende, uso dos mesmos e método para o tratamento ou profilaxia de diabetes e outras enfermidades

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]